Deeptech medical device startup Articulus Surgical has raised an undisclosed amount in a seed funding round led by Kalaari Capital. The startup is developing an indigenous, interoperable surgical robotics ecosystem designed for minimally invasive soft-tissue surgery, with a focus on India and global scalability.
The funding will be deployed to accelerate market rollout, expand hospital deployments, strengthen surgeon training initiatives, and deepen strategic partnerships across the country.
Tackling the Low Penetration of Robotic Surgery
Despite over 200 million abdominal surgeries performed worldwide each year, robotic surgery adoption remains strikingly low—around 5% globally and under 1% in India.
Articulus Surgical aims to address this gap with an India-built platform capable of performing high-volume procedures across diverse healthcare settings. The startup’s focus is on making precision, minimally invasive surgery more accessible and scalable for hospitals and surgeons in India.
Founder’s Vision: Make-in-India With Global Relevance
Saurya Mishra, Founder and CEO of Articulus Surgical, highlighted the mission behind the startup:
“This funding allows us to shift focus to scale and adoption, bringing advanced, minimally invasive surgical technology to more hospitals and surgeons, while staying true to our self-reliant Make-in-India vision with global relevance, driven by a great, young team and an unwavering focus on patient care.”
The startup emphasizes patient safety, surgeon adoption, and high operational efficiency, all while ensuring the technology remains affordable and locally developed.
Investor Perspective: Addressing India’s Healthcare Gap
Pranav Koshal, Vice President at Kalaari Capital, said:
“Accessible, high-quality healthcare remains one of the most critical whitespace opportunities in India, where millions of patients still lack access to world-class surgical care. We’re excited to back Saurya and the team at Articulus Surgical, who are building a vertically integrated, India-native platform of affordable robotic surgical systems. Their approach is focused on bringing precision, safety, and minimally invasive procedures within reach of surgeons and patients across the country—precisely the kind of impact-driven innovation India needs.”
Investors see India-native surgical robotics platforms as key to expanding access to quality care while reducing costs and procedural risks.
Key Areas of Focus Post-Funding
With the seed funding, Articulus Surgical plans to:
-
Accelerate Market Rollout: Deploy surgical robotics across more hospitals nationwide.
-
Expand Hospital Deployments: Build partnerships with leading healthcare providers for high-volume surgical procedures.
-
Strengthen Surgeon Training: Establish training programs to ensure safe, efficient adoption of robotic systems.
-
Deepen Strategic Partnerships: Collaborate with hospitals and healthcare institutions to increase technology adoption.
-
Enhance Platform Development: Continue refining the India-built robotic surgical ecosystem for broader use.
This strategy positions Articulus Surgical to bridge the gap between low robotic surgery penetration and the growing demand for minimally invasive procedures in India.
Why Articulus Surgical Stands Out
-
India-Built Technology: A homegrown surgical robotics ecosystem designed for affordability and scale.
-
High-Volume Capability: Optimized for common soft-tissue procedures across diverse hospital settings.
-
Impact-Driven Innovation: Focused on patient safety, procedural precision, and cost-effective adoption.
-
Scalable Training Programs: Ensures that hospitals and surgeons can adopt the technology efficiently.
By combining deeptech innovation with operational scalability, Articulus Surgical is positioning itself as a key player in India’s robotic surgery ecosystem.
Looking Ahead
As robotic surgery adoption in India remains under 1%, startups like Articulus Surgical represent a transformative opportunity to improve patient care, enhance precision, and reduce surgical risk.
With Kalaari Capital’s support, the startup is poised to roll out its platform across hospitals nationwide, train surgeons, and expand its Make-in-India robotics ecosystem for minimally invasive surgery.
This investment signals growing interest in deeptech healthcare startups that combine homegrown innovation, affordability, and large-scale impact.
